Turner syndrome

Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Turner syndrome: Williams syndrome, Noonan syndrome

Tur·ner syndrome

 (tûr′nər) also Tur·ner's syndrome (-nərz)
A congenital condition of girls and women caused by complete or partial absence or deficiency of one X chromosome, characterized by short stature, a webbed neck, low-set ears, skeletal abnormalities, and infertility owing to ovarian failure.

[After Henry Hubert Turner (1892-1970), American endocrinologist.]
References in periodicals archive ?
1] Patients with 45,X/46,XY mosaicism benefit from growth hormone therapy, similar to patients with Turner syndrome and as demonstrated in our patient.
For women with Turner syndrome, the guidelines call for assessment by a cardiologist with a special interest in adult congenital heart disease, as well as a general medical and endocrine examination prior to pregnancy.
The purpose of this article is to provide a clinical presentation of patients with Turner syndrome and promote early detection, diagnosis and safe dental treatment.
Turner Syndrome is a genetic illness which affects one in 2500 female babies.
The Turner Syndrome Support Society is holding a meeting in Solihull as part of its first annual awareness week.
This Phase IV open-label study for predictive markers of response to treatment in pre-pubertal children with growth hormone deficiency (GHD) or Turner syndrome (TS) treated with Saizen(R), is one of the largest prospective studies conducted in endocrinology in GHD and TS, exploring the relationship between short-term biomarker changes, genotyping (DNA) and gene expression profiling (mRNA).
Jennifer Wakenell, 17, of Livonia, a senior at Divine Child High School in Dearborn, created a campaign to raise awareness of Turner Syndrome and nonverbal learning disabilities.
Revenues for Adult GHD, Turner Syndrome & Idiopathic Short
Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal sex determination.
He was directly involved in the efforts that led to approval of growth hormone use in children with Turner syndrome and chronic renal insufficiency.
Such a platform can improve delivery for a number of gene therapies including Factor VIII and Factor IX clotting factors for hemophiliacs, insulin for Type I and Type II diabetics, erythropoietin for anemia, and growth hormone for dwarfism and patients suffering from Turner Syndrome.